Sangeetha Venugopal

1.3k total citations
44 papers, 583 citations indexed

About

Sangeetha Venugopal is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Sangeetha Venugopal has authored 44 papers receiving a total of 583 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Hematology, 19 papers in Molecular Biology and 19 papers in Genetics. Recurrent topics in Sangeetha Venugopal's work include Acute Myeloid Leukemia Research (29 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (15 papers) and Chronic Myeloid Leukemia Treatments (12 papers). Sangeetha Venugopal is often cited by papers focused on Acute Myeloid Leukemia Research (29 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (15 papers) and Chronic Myeloid Leukemia Treatments (12 papers). Sangeetha Venugopal collaborates with scholars based in United States, India and Malaysia. Sangeetha Venugopal's co-authors include John Mascarenhas, Farhad Ravandi, Naval Daver, Michal Bar‐Natan, Mikkael A. Sekeres, Justin M. Watts, Tapan M. Kadia, Hagop M. Kantarjian, Gautam Borthakur and Marina Konopleva and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Sangeetha Venugopal

38 papers receiving 577 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sangeetha Venugopal United States	13	336	254	162	105	81	44	583
Geoffroy Venton France	13	191 0.6×	147 0.6×	101 0.6×	116 1.1×	59 0.7×	53	497
Estelle Verburgh South Africa	10	447 1.3×	437 1.7×	227 1.4×	100 1.0×	43 0.5×	35	824
Rayaz Ahmed India	12	286 0.9×	122 0.5×	105 0.6×	104 1.0×	50 0.6×	55	459
María Collado Spain	13	135 0.4×	209 0.8×	98 0.6×	67 0.6×	55 0.7×	17	488
Naoko Hosono Japan	14	341 1.0×	317 1.2×	129 0.8×	75 0.7×	16 0.2×	60	646
Luciana Correa Oliveira de Oliveira Brazil	10	181 0.5×	138 0.5×	60 0.4×	88 0.8×	25 0.3×	31	330
Ernesto Pérez Persona Spain	9	462 1.4×	302 1.2×	149 0.9×	235 2.2×	45 0.6×	24	580
Pimjai Niparuck Thailand	12	160 0.5×	77 0.3×	84 0.5×	84 0.8×	85 1.0×	56	405
Samer K. Khaled United States	20	589 1.8×	240 0.9×	174 1.1×	198 1.9×	51 0.6×	65	950
Chiara Maria Dellacasa Italy	15	457 1.4×	346 1.4×	417 2.6×	120 1.1×	37 0.5×	37	752

Countries citing papers authored by Sangeetha Venugopal

Since Specialization

Citations

This map shows the geographic impact of Sangeetha Venugopal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sangeetha Venugopal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sangeetha Venugopal more than expected).

Fields of papers citing papers by Sangeetha Venugopal

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sangeetha Venugopal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sangeetha Venugopal. The network helps show where Sangeetha Venugopal may publish in the future.

Co-authorship network of co-authors of Sangeetha Venugopal

This figure shows the co-authorship network connecting the top 25 collaborators of Sangeetha Venugopal. A scholar is included among the top collaborators of Sangeetha Venugopal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sangeetha Venugopal. Sangeetha Venugopal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bazinet, Alexandre, Ziyi Li, Juan José Rodríguez‐Sevilla, et al.. (2024). Cytogenetic and Molecular Associations with Outcomes in Higher-Risk Myelodysplastic Syndromes Treated with Hypomethylating Agents plus Venetoclax. Clinical Cancer Research. 30(7). 1319–1326. 3 indexed citations

Sekeres, Mikkael A., Hetty E. Carraway, Richard M. Stone, et al.. (2024). A Multicenter, Phase Ib/II Study That Combines Luspatercept and Lenalidomide (L2) in Lower-Risk, Non-Del(5q) Patients with Myelodysplastic Syndromes: Phase Ib Results. Blood. 144(Supplement 1). 1821–1821. 1 indexed citations

Handa, Shivani, Richard Butterfield, Sangeetha Venugopal, et al.. (2024). TP53 Alterations Confer Increased Risk of Leukemic Transformation and Worse Survival As Compared to High Molecular Risk Mutations in Patients with Myeloproliferative Neoplasms. Blood. 144(Supplement 1). 243–243.

Venugopal, Sangeetha & Justin M. Watts. (2023). The future paradigm of HMA + VEN or targeted inhibitor approaches: sequencing or triplet combinations in AML therapy. Hematology. 2023(1). 192–197. 6 indexed citations

Venugopal, Sangeetha & Justin M. Watts. (2023). Olutasidenib: from bench to bedside. Blood Advances. 7(16). 4358–4365. 19 indexed citations

Venugopal, Sangeetha & Sanam Loghavi. (2023). Current State and Future Prospects of Diagnosis and Management of <i>TP53</i>-Mutated Myeloid Neoplasms. Pathobiology. 91(1). 45–54. 1 indexed citations

Bataller, Álex, Alexandre Bazinet, Sangeetha Venugopal, et al.. (2023). S172: PHASE 1/2 STUDY OF ORAL DECITABINE/CEDAZURIDINE IN COMBINATION WITH VENETOCLAX IN TREATMENT-NAÏVE HIGHER-RISK MYELODYSPLASTIC SYNDROMES OR CHRONIC MYELOMONOCYTIC LEUKEMIA. HemaSphere. 7(S3). e18588ff–e18588ff. 3 indexed citations

Venugopal, Sangeetha, Zhuoer Xie, & Amer M. Zeidan. (2023). An overview of novel therapies in advanced clinical testing for acute myeloid leukemia. Expert Review of Hematology. 16(2). 109–119.

Venugopal, Sangeetha, Gautam Borthakur, Naval Daver, et al.. (2022). Validation of ALFA 1200 score in patients with AML >60 years treated with double nucleoside–based low-intensity therapy. Blood Advances. 6(19). 5546–5549. 1 indexed citations

10.

Venugopal, Sangeetha, Koichi Takahashi, Naval Daver, et al.. (2022). Efficacy and safety of enasidenib and azacitidine combination in patients with IDH2 mutated acute myeloid leukemia and not eligible for intensive chemotherapy. Blood Cancer Journal. 12(1). 10–10. 63 indexed citations

11.

Bazinet, Alexandre, Tapan M. Kadia, Sangeetha Venugopal, et al.. (2022). A retrospective study of cladribine and low‐dose cytarabine–based regimens for the treatment of chronic myelomonocytic leukemia and secondary acute myeloid leukemia. Cancer. 129(4). 560–568. 6 indexed citations

12.

Daver, Naval, Sangeetha Venugopal, & Farhad Ravandi. (2021). FLT3 mutated acute myeloid leukemia: 2021 treatment algorithm. Blood Cancer Journal. 11(5). 104–104. 96 indexed citations

13.

Venugopal, Sangeetha, Mahran Shoukier, Marina Konopleva, et al.. (2021). Outcomes in patients with newly diagnosed TP53‐mutated acute myeloid leukemia with or without venetoclax‐based therapy. Cancer. 127(19). 3541–3551. 43 indexed citations

14.

Venugopal, Sangeetha, Naval Daver, & Farhad Ravandi. (2021). An Update on the Clinical Evaluation of Antibody-Based Therapeutics in Acute Myeloid Leukemia. Current Hematologic Malignancy Reports. 16(1). 89–96. 10 indexed citations

15.

Venugopal, Sangeetha, Kelly S. Chien, Danielle Hammond, et al.. (2021). Outcomes of Patients with Chronic Myelomonocytic Leukemia (CMML) Treated with Hypomethylating Agents. Blood. 138(Supplement 1). 2613–2613. 3 indexed citations

16.

Venugopal, Sangeetha, John Mascarenhas, & David P. Steensma. (2020). Loss of 5q in myeloid malignancies – A gain in understanding of biological and clinical consequences. Blood Reviews. 46. 100735–100735. 14 indexed citations

17.

Venugopal, Sangeetha, Selena Zhou, Siraj M. El Jamal, Andrew A. Lane, & John Mascarenhas. (2019). Blastic Plasmacytoid Dendritic Cell Neoplasm–Current Insights. Clinical Lymphoma Myeloma & Leukemia. 19(9). 545–554. 23 indexed citations

18.

Venugopal, Sangeetha & John Mascarenhas. (2018). Chronic Neutrophilic Leukemia: Current and Future Perspectives. Clinical Lymphoma Myeloma & Leukemia. 19(3). 129–134. 2 indexed citations

19.

Venugopal, Sangeetha, et al.. (2017). Breast cancer in patients with Li–Fraumeni syndrome – a case-series study and review of literature. Breast Cancer Targets and Therapy. Volume 9. 207–215. 13 indexed citations

20.

Derman, Olga, Qiang Liu, Hatef Massoumi, et al.. (2017). Ibrutinib‐induced severe liver injury. Clinical Case Reports. 5(6). 735–738. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact